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Torus Palatinus: A New Anatomical Correlation with
Bone Density in Postmenopausal Women
JOSEPH L. BELSKY, JOSEPHINE S. HAMER, JANET E. HUBERT, KARL INSOGNA, AND
WILLIAM JOHNS
Departments of Medicine (J.L.B.) and Nuclear Medicine (J.E.H., W.J.), Danbury Hospital, Danbury, Connecticut 06810;
Department of Mathematics, Western Connecticut State University (J.S.H.); and Department of Medicine, Yale University
School of Medicine (K.L.), New Haven, Connecticut 06520
The observation that subjects who have a striking oral exos-
tosis, called torus palatinus, also tended to have normal or
high bone densities prompted us to examine an unselected
population referred for bone density assessment for a possible
correlation with torus palatinus. Subjects referred from com-
munity physicians had a visual examination of the open
mouth to estimate the size of any torus palatinus (0 for none/
trace to 5 for very large) before undergoing a bone density
measurement by dual energy x-ray absortiometry. Bone den-
sity T- and z-scores were correlated with the size of each sub-
ject’s torus palatinus. Torus size groups were also correlated
with other variables affecting bone density. About 20% of 370
postmenopausal female subjects, >90% Caucasian, had a mod-
erate to large torus palatinus. Regression correlations for
torus size were modest, but significantly related to T- and
z-scores of lumbar vertebrae and left hip (P < 0.01 for each).
Differences due to medication, body mass index, smoking,
parity, and several other factors that affect bone density did
not diminish the relation to torus size. This study shows a
small, but significant, positive relation for postmenopausal,
Caucasian women between bone mineral density and torus
size after controlling for several variables known to affect
bone density were examined. Torus prominence, in associa-
tion with other factors, can be considered in decisions for
testing bone density in otherwise normal postmenopausal
women. (J Clin Endocrinol Metab 88: 2081–2086, 2003)
TORUS PALATINUS IS A bony prominence at the middleof the hard palate (1, 2). The size varies from barely
discernible to very large, from flat to lobular. This and other
oral exostoses (torus mandibularis and torus maxillaris) are
not a disease or a sign of disease, but, if large, may be a
problem in the construction and wearing of dentures. These
oral exostoses are usually composed of mature dense can-
cellous bone with a rim of cortical bone of variable thickness
(1, 2). Occasional minimal osteoblastic activity or even he-
mopoietic marrow can be seen (2).
Bone density determinations are commonly sought to di-
agnose and follow patients with osteoporosis, a disease of
low bone mass and increased risk for bone fracture and its
consequences. Although there are biochemical correlations
of bone loss and gain and a variety of techniques for bone
mass measurements, the current gold standard is dual x-ray
absorptiometry (DEXA). Although it is clear that the majority
of the observed variance in peak adult bone mass is genet-
ically inherited (3), the genes responsible for controlling skel-
etal mass are largely unknown. Recently two families with
high bone mass have been found to have a unique gene
product linked to the gene for low-density lipoprotein
receptor-related protein 5 (LRP5) (4, 5). In these families an
amino acid substitution resulted in a mutated gene on chro-
mosome 11q12–13 that produced a gain of function affecting
bone deposition (3, 4).
High bone mass is an uncommon finding (6) that, in most
cases, is associated with a reduced risk of skeletal fracture.
In the course of investigating one family with high bone mass
associated with a gene mutation (4) and also in the clinical
practice of one of us (J.L.B.), many patients with a prominent
torus palatinus were noted to have normal or high bone
densities. We postulated that the presence and especially the
size of a torus palatinus may be correlated with increased
bone mineral density (BMD), and we undertook the follow-
ing study to test this hypothesis in an unselected, unrelated,
community population.
Subjects and Methods
All subjects were referred to the Danbury Hospital Nuclear Medicine
Department by their physicians for bone densitometry determinations by
DEXA using a Lunar-DPX-L (Lunar Corp., Chicago, IL). Imaging of the
second through fourth lumbar vertebrae and left hip was performed by a
trained technician (J.E.H.) who administered a questionnaire intended to
elicit osteoporosis risk factors. The patient was informed of the investigation
and volunteered to undergo visual inspection of the oral cavity. The palate
was not palpated. An estimated palatal torus size grade (0 indicating none/
trace to 5 indicating very large), based on comparison with a pictorial series
of torus sizes, was assigned without knowledge of the DEXA outcome. A
second torus size grader confirmed the size assignment in the initial study
phase and thereafter about 10% of the assignments. Rarely was an assigned
size altered, and then only by one grade. Agreement by two observers
ensured reasonable reproducibility of size assignments despite the quali-
tative nature of this method. A torus palatinus judged to be grade 1 (small)
and one graded 5 (large) are shown in Fig. 1. Bone density results are
expressed as the deviation from the reference means for sex- and race-
matched individuals in the general population. The T-scores compare sub-
jects with young adults and the z-scores compare subjects with reference
values for age-, sex-, and race-matched subjects. This study, including the
form of consent, was approved by the Danbury Hospital institutional
review board.
Statistical methods
Pearson product-moment correlations (7, 8) were computed to ex-
amine a linear relationship between torus, using all graded measures of
Abbreviations: BMD, Bone mineral density; DEXA, dual energy x-ray
absortiometry; HRT, hormone replacement therapy.
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torus sizes (0 to 5) and the T- and z-scores of the second to fourth lumbar
vertebrae and left hip.
To eliminate other possible confounding variables, partial correla-
tions (9) were found between torus size and the second to fourth lumbar
vertebrae and left hip scores, and tests of differences among the torus
measurements were conducted for the available data. Torus measure-
ments were categorized into three torus size grade groups to enlarge
group size for greater statistical emphasis: absent/trace (size, 1),
small/moderate (size, 1–2), and large (size, 3). Preliminary analysis
showed no significant differences between a numerical size group and
its neighbor within the combined categories. ANOVA (5) was used to
determine whether bone density differences among the three torus size
groups could be attributed to the continuous variables. 2 analyses (7,
9) were used to test for independence of torus and the categorical
variables (Table 1). Minitab and SPSS (SPSS, Inc., Chicago, IL) were used
for all statistical analyses (10, 11).
Results
Complete datasets were available for a total of 469 subjects
who were community-based, nonselective, overwhelmingly
Caucasian (90%), and postmenopausal (82% of 452 females;
age range, 16–89 yr). Correlation of torus sizes with bone
density using all available data points for the total population
was highly significant (P  0.01). Findings only in the Cau-
casian postmenopausal women form the basis for further
analyses of the relationship between torus palatinus and
bone density. The number of males, premenopausal women,
and African-American subjects were too few for meaningful
separate analyses. There were 279 postmenopausal Cauca-
sian women with no/trace discernible torus, 25 with grade
1, 21 with grade 2, 20 with grade 3, 13 with grade 4, and 10
with grade 5. Mandibular tori and other oral exostoses were
only rarely seen. Although the prevalence of oral exostoses
may increase with age (1), our subjects who were aware of
prominent tori reported that these were present lifelong and
had not changed in size, number, or appearance. We found
that many subjects were unaware of even a large torus until
their fifties or older.
For postmenopausal women the correlation between torus
size and the T-score for lumber vertebra 2–4 was 0.264, and that
for T-score for hip was 0.211 (both P  0.01). Scatterplots for
T-score for lumber vertebra 2–4 and T-score for hip compared
with torus sizes 0–5 including all postmenopausal female sub-
jects are shown in Fig. 2. Correlations were similar between
torus size and z-scores and were 0.223 for lumbar 2–4 and 0.205
for left hip (both P 0.01; not shown). We also combined torus
sizes into three categories [absent/trace (size,1), small/mod-
erate (size, 1–2), and large (size, 3)] to facilitate further anal-
ysis. Box plots of T-scores (Fig. 3) illustrate this correlation.
When these findings were controlled for differences in factors
that may affect bone mineral density (Table 1), the partial cor-
relations for T-scores were 0.251 and 0.227 (both P  0.01) for
lumbar vertebra 2–4 and hip, respectively. Partial correlations
FIG. 1. Top, A small torus palatinus. Bottom, A large torus palatinus.
TABLE 1. Characteristics of postmenopausal sample
Torus size
P
None/trace Moderate Large
Total no. 276 46 42
Age
Mean 60.01 57.74 55.50 0.138a
Range 24–82 46–84 39–89
Smokersb
Yes 44 3 8
No 230 43 34 0.189c
1 yr HRT
Yes 87 12 17
No 174 30 22 0.332c
BMI
Mean 27.64 26.44 27.29 0.431a
Range 18–58 18–45 20–47
Parity
Mean 2.81 2.73 2.08 0.073a
Range 0–13 0–8 0–4
Thyroid medication
No 227 38 39
Yes 49 7 3 0.219c
Steroid medication
No 239 39 40
Yes 39 7 2 0.228c
Age at menopause
Mean 47.81 49.09 47.93 0.371a
Range 20–70 24–57 30–55
Fractures
No 240 38 34
Hip/spine 20 3 2 0.899c
All fractures 37 8 4 0.643c
a P values based on ANOVA.
b Nonsmokers include those who have quit for 5 or more years.
c P values on 2 test.
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for z-scores were 0.227 for lumbar vertebra 2–4 and 0.197 for hip
(both P  0.01).
ANOVAs for bone density variables using the three size
groups were highly significant (P  0.01) for T-scores (Fig.
4) and also for z-scores (not shown) for our postmenopausal
subjects.
Examination of other factors associated with or affecting
BMD (Table 1) showed none of these to be significantly related
to torus size. Only lower parity shows a trend (P  0.073)
associated with increasing size of torus. Torus sizes were sim-
ilarly prevalent among those with and without diabetes, a con-
dition that may be associated with decreased bone density.
Comparison of torus size in the one-third of postmenopausal
women in our population who never received hormone re-
placement therapy (HRT) or who were treated for less than 1
yr also showed a positive correlation between torus size and
bone density. The proportions of subjects in the three torus
categories of non-HRT-treated women (torus sizes: absent/
trace, 77%, small/moderate, 13%; large, 10%) were virtually
identical with those in HRT-treated subjects (75%, 10%, and
15%, respectively). Although not reaching statistical signifi-
cance, we found that estrogen-deficient subjects, smokers, and
those receiving chronic steroid therapy also showed a positive
relationship between torus size and BMD.
Discussion
Our observations strongly suggest that postmenopausal
Caucasian women with large torus palatinus have a higher
mean bone density than their peers as well as a higher bone
density than much younger women. A similar association
has previously been suggested. Hjertstedt et al. (12) reported
FIG. 2. Comparison of lumbar and hip bone densities of
subjects with younger women (T-scores with least
squares regression line). Upper panel, Plot of torus pal-
atinus size on T-scores for lumbar vertebra 2–4 (r 0.264
for the mean; P  0.01). Lower panel, Torus size on T-
scores for hip (r  0.211; P  0.01).
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in 2001 on the relationship of mandibular and palatal tori to
BMD among 101 females and 129 males over 70 yr of age.
Although most correlations were lower than the present
study, there was a significant relationship among females
between the presence of mandibular tori with BMD at the
femoral neck (P 0.03) and trochanter (P 0.04). There was
no significant correlation for male subjects. Palatal tori
showed a significant relationship (P  0.04 for proximal
radius and P  0.01 for distal radius) only for male and
females combined, but not for females separately. The larger
numbers of subjects in our study likely account for the stron-
ger correlations we observed. We suspect the association of
bone density and large oral exostoses probably also applies
to premenopausal women, males, and non-Caucasians, al-
though our sample has too few subjects in these categories
to confirm this. Yoda et al. (13) reported in an abstract that
9 elderly females with palatal tori had higher BMD z-scores
at the femoral neck, but not lumbar spine and radius com-
pared with 24 females without palatal tori. No significant
association was found in males.
In the present study both estrogen-replaced women and
those not taking HRT have a positive correlation of torus size
with bone density of the lower spine and hip, suggesting that
this is not an artifact of antiresorptive therapy.
Kolas et al. (14) reported the prevalence of torus palatinus
and torus mandibularis in 2478 dental patients (85% Cau-
casian) as 14.7% in males and 26.73% in females (24% for
females in our study). A higher prevalence of oral exostoses
FIG. 3. Box plots for T-scores among torus size
groups. The horizontal line in the box center is the
median score; the vertical lines show lower and up-
per quartiles of the T-scores. The solid dot indicates
the mean for each torus group. Each asterisk denotes
an outlier. Upper panel, T-scores for hip. Lower
panel, T-scores for lumbar vertebra 2–4.
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was reported for other racial groups, including Peruvians,
Native Americans, Japanese, Thais, and Eskimos (12, 13). The
occurrence increases with age (1, 12, 13), achieving a plateau
by the third decade, a period when peak bone mass is usually
achieved. In the present study subjects reported no size
changes with aging. Suzuki and Sakai (15) reported an au-
tosomal dominant pattern of inheritance in 150 families in
Japan and found that the more marked the development of
torus palatinus in the parents the higher the frequency in
their children.
Identification of women at-risk for osteoporosis has be-
come a major issue in health care due in part to the significant
cost of testing and to low test specificity (16). Guidelines for
cost-effective screening to identify individuals with osteo-
porosis were recently reviewed by Cadarette et al. (16) and
included older age, lower body weight, and absence of estrogen
therapy. Personal or family history of fracture, cigarette use,
race, and rheumatoid arthritis were noted as additional risk
factors. Clinicians may also weigh other considerations in de-
ciding to test for the presence of osteoporosis, including loss of
height, chronic steroid or l-thyroxine therapy, the presence of
type I diabetes, hypogonadism, immobility, vitamin D defi-
ciency, or hyperparathyroidism. In daily practice there is in-
creasing pressure to have bone density measured even when
none or few of the above criteria are present.
In individual subjects there are no clear signs or symptoms
that indicate the presence of normal or high bone density
[with the exception of the unique family with very large,
lobulated palatal and other oral exostoses who have a mu-
tation conveying unusually high bone density (4) or in spe-
cific, rare conditions (6)]. Epidemiological studies have
shown that mean bone densities are higher in people who are
obese, in younger subjects, and in African-Americans. To
these can now be added the easily noted presence of torus
palatinus and perhaps torus mandibularis (12), especially if
these prominences are large. However, even this finding
must be judged in conjunction with all other risk factors in
individual assessments.
Our findings of suggestive associations between both de-
creased parity as well as younger mean age (Table 1) among
those with the largest torus palatinus (and increased bone
density) are intriguing and need further study.
The precise mechanism for the positive relation of torus
size to bone density is unknown. Indeed, polymorphism in
the LRP5 gene (3) (or other genes not yet identified) may
signal a process that enhances bone deposition (4), and fur-
FIG. 4. ANOVA tests of three torus size groups with T-scores. Upper panel, T-scores for hip; lower panel, T-scores for lumbar vertebra 2–4.
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ther molecular genetic studies could target subjects and their
families with large torus.
The relation of torus size to bone density needs further
confirmation, including assessment of males, premeno-
pausal women, and families with inherited large tori. Clearly
several hundred subjects are required for such studies in
view of the small r values noted in this and other reports (12,
13). More precise quantification of torus size or shape may
be desirable, but is not expected to significantly alter the
relationship reported. Osteoarthritic changes in aging ver-
tebrae can confound DEXA interpretation of bone density,
resulting in artifactually higher BMD values. Although the
present study could not estimate the degree of this effect,
review of the DEXA images showed similar lumbar osteo-
arthritic changes in all torus groups. A study of torus pal-
atinus and other large oral exostoses and bone density in
subjects in the third and fourth decades of life could mini-
mize this potential interference.
Examination of the hard palate should be considered a
routine part of the physical examination in postmenopausal
women and, in fact, in all patients in conjunction with bone
density measurement.
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